AgelessRx markets prescription NAD+ injections through an online evaluation and subscription service. Its public page discusses ongoing messaging and check-ins, which makes the follow-up arrangement an important part of the buying decision.
The advertised starting price is not the entire cost story. In this review we separate the initial offer, the care process, and the evidence behind the claims. We reviewed public sources, not a personal treatment experience, and did not independently test its medication.
Read the full three-month billing terms before judging the $79 introductory headline.
Start with the payment schedule
The product page displayed $79 for the first month on a three-month plan billed in full, with $149 per month afterward. It also described monthly and three-month plan choices. Because the displayed offer mixes a monthly equivalent with an upfront billing term, confirm the full amount charged at enrollment and renewal.
Do not assume that selecting a three-month plan means you can pay one month at a time. Ask how a pause or cancellation affects an order already prescribed, processed, or shipped. The cost guide shows why initial price and ongoing cost should sit in separate columns.
What the online service describes
AgelessRx describes an online clinical assessment, pharmacy fulfillment, shipping, and continuing support. Its injection page identifies a subcutaneous route. That describes administration beneath the skin, but the specific directions must come from the clinician and the label for the product actually supplied.
If vision, dexterity, or a fear of needles could make self-administration difficult, bring that up before paying. Ask whether training can be repeated and whether a caregiver may participate in teaching with your permission. The relevant question is whether the service fits your needs, not how quickly someone else learned.
How to read the customer results
The page includes a customer survey about perceived benefits. A survey can help describe what respondents report, but it does not provide the same evidence as a blinded randomized trial. People who respond may differ from those who stop treatment, and changes in sleep, routines, or expectations can influence the answers.
A percentage of respondents feeling better cannot tell you the chance that your own fatigue will improve because of this particular injection. It also does not establish that the treatment lengthens life. We explain these distinctions in what NAD+ research actually shows.
Research credentials and product evidence are different
A provider may participate in research or employ qualified scientists while still selling a preparation that has not been proven for a specific benefit in a controlled trial. Read each study for the exact ingredient, route, population, comparison group, and measured outcome.
For example, a study of oral precursors or a prolonged IV infusion cannot settle whether a home subcutaneous preparation will improve memory. When a page cites a paper, ask the clinician to connect that paper to the claim being made about your treatment goal. A clear explanation should include what remains unknown.
Check the pharmacy and your support route
The company states that licensed US pharmacies prepare the medication. Before treatment, obtain the pharmacy name and verify the relevant license through the state regulator. Ask about shipment handling, beyond-use dating, and what to do if the package arrives late or warm.
Also ask which team answers clinical questions and which handles billing. A subscription should not leave you uncertain whether a message goes to customer service, a prescriber, or a pharmacist. Our online visit checklist can help you record those contact details.
Compare the offer on the same terms
Our CoreAge Rx review describes a different public offer, including a price discrepancy that should be resolved before checkout. Our IVY RX review covers an advertised starting price whose supply period needs clarification. Neither comparison proves one medication works better.
Put each quote beside its plan duration, total initial charge, renewal amount, supply details, and follow-up access. That makes an affordable-looking promotion easier to judge against the amount you will actually commit. If a provider will not give a clear written answer, keep researching.
Make a subscription decision before a treatment decision
Consider whether the initial commitment is comfortable even if the clinician recommends stopping early. Ask which charges become nonrefundable after an order reaches the pharmacy and whether the next shipment can be changed before processing. Save the answer with your order confirmation.
Then consider the clinical plan independently. A three-month billing cycle is not evidence that you need three months of treatment, and a renewal reminder is not a reassessment of whether the original goal has been met. Ask how the service separates billing events from clinical follow-up.
If you want to compare providers, carry the same written questions to each one. That makes it easier to distinguish a responsive support process from a persuasive sales page. Our review can identify the questions, but the answers must reflect the plan you would actually purchase.
Before deciding on AgelessRx
AgelessRx may be worth investigating if you prefer an online subscription with a defined support process. The strongest next step is to confirm the financial commitment and agree on what the clinician will monitor. Persistent symptoms still deserve a broader medical evaluation.
- Request the initial three-month charge and renewal charge in writing.
- Ask what happens to charges after a pause or cancellation.
- Confirm the pharmacy, state eligibility, and teaching process.
- Choose a follow-up date and discuss when to discontinue.
Follow the source
References & further reading
- AgelessRx — NAD+ Injection
Provider page. Promotional pricing depends on the selected plan.
- FDA — ingredients suitable for sterile compounding
Reports NAD+ injectable adverse events and ingredient-quality concerns.
- FDA — compounding questions and answers
Compounded drugs are not FDA-approved or reviewed before marketing for safety, effectiveness, or quality.
- Grant et al. (2019) — human NAD+ infusion pilot
Small IV metabolism study; does not establish benefits of home injections.